Abdominal visceral fat accumulation is associated with hippocampus volume in non-dementia patients with type 2 diabetes mellitus

Obesity is associated with cognitive dysfunction, for which changes in the hippocampus plausibly play a pivotal role. We tested the hypothesis that an elevated level of visceral fat accumulation (VFA) correlates with hippocampus volume and insulin resistance in non-dementia patients with type 2 diabetes. Subjects included 48 non-dementia patients with type 2 diabetes, who were divided into two groups, high VFA group (mean+/-standard deviation: age=65+/-6 years, n=30) and normal VFA group (65+/-5 years, n=18). Hippocampus volume has been quantitated with computer-assisted analysis using a magnetic resonance imaging (MRI) voxel-based specific regional analysis system developed for the study of Alzheimer's disease (VSRAD), which yields a Z-score as the end point for assessment of hippocampal volume. The Z-score was higher in the high VFA group than in the normal VFA group (p<0.0001). The fasting plasma glucose (p<0.05) and insulin concentrations (p<0.0001) and the homeostasis model assessment (HOMA) index (p<0.0001) were higher in the high VFA group than in the normal VFA group. Multiple regression analysis showed that VFA levels were independently predicted by Z-score and HOMA index. Our results indicate that the elevated level of VFA in Japanese non-dementia patients with type 2 diabetes is characterized by increased hippocampus volume and insulin resistance, and that the Z-score and HOMA index are independent predictors of VFA.

[1]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[2]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[3]  Guenter Corssen,et al.  Alcohol‐Induced Pituitary Adenolysis: How Does It Control Intractable Cancer Pain?—An Experimental Study Using Tooth Pulp‐Evoked Potentials in Rhesus Monkeys , 1979 .

[4]  E. Bertin,et al.  Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. , 2000, Diabetes & metabolism.

[5]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[6]  A. Barnett,et al.  Increased resistin gene and protein expression in human abdominal adipose tissue. , 2002, The Journal of clinical endocrinology and metabolism.

[7]  Å. Cederblad,et al.  Adipose tissue volume determination in males by computed tomography and 40K. , 1988, International journal of obesity.

[8]  D. Simonson,et al.  Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. , 2001, The Journal of clinical endocrinology and metabolism.

[9]  B. McEwen,et al.  Glucose transporter expression in the central nervous system: relationship to synaptic function. , 2004, European journal of pharmacology.

[10]  S. Baxendale,et al.  Amnesia in temporal lobectomy patients: Historical perspective and review , 1998, Seizure.

[11]  K. Tsuchihashi,et al.  Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.

[12]  P. Raskin,et al.  A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. , 1999, American journal of hypertension.

[13]  S. Lipsitz,et al.  Generalized estimating equations for correlated binary data: Using the odds ratio as a measure of association , 1991 .

[14]  平田 容子,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2007 .

[15]  Dan Mungas,et al.  Central obesity and the aging brain. , 2005, Archives of neurology.

[16]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[17]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[18]  Masafumi Matsuda,et al.  Metabolic effects of visceral fat accumulation in type 2 diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[19]  A. Folsom,et al.  Multiple Metabolic Syndrome Is Associated With Lower Heart Rate Variability: The Atherosclerosis Risk in Communities Study , 1998, Diabetes Care.

[20]  N. Hindley,et al.  Neuroimaging and early Alzheimer's disease , 1996, The Lancet.

[21]  J. Lindsay,et al.  Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.

[22]  B. Pappas,et al.  Hippocampal nitric oxide upregulation precedes memory loss and Aβ 1-40 accumulation after chronic brain hypoperfusion in rats , 2003, Neurological research.

[23]  E. Boyko,et al.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. , 2000, Diabetes care.

[24]  S. Doré,et al.  Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats , 1997, Neuroscience.

[25]  T. Funahashi,et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.

[26]  P A Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[27]  L. Reagan,et al.  Insulin signaling effects on memory and mood. , 2007, Current opinion in pharmacology.

[28]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[29]  D. Amaral,et al.  Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging , 1989, Nature.

[30]  C A Roe,et al.  Statistical Comparison of Two ROC-curve Estimates Obtained from Partially-paired Datasets , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  P. Arner.  Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[32]  D. Bennett,et al.  From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy , 2000, Annals of the New York Academy of Sciences.

[33]  J. Ashburner,et al.  Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.

[34]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[35]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[36]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[37]  S. Kahn,et al.  Visceral Adiposity and the Prevalence of Hypertension in Japanese Americans , 2003, Circulation.

[38]  L. Lerman,et al.  Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. , 2007, American journal of physiology. Heart and circulatory physiology.

[39]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[40]  Y. Matsuzawa,et al.  Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. , 1997, Diabetes/metabolism reviews.

[41]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[42]  S. Woods,et al.  Intracerebroventricular insulin enhances memory in a passive-avoidance task , 2000, Physiology & Behavior.

[43]  R. Brooks,et al.  NO-Dependent Vasorelaxation Is Impaired After Gene Transfer of Inducible NO-Synthase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[44]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[45]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[46]  S. Yamashita,et al.  Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.

[47]  C. R. Park,et al.  Cognitive effects of insulin in the central nervous system , 2001, Neuroscience & Biobehavioral Reviews.

[48]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[49]  D. Alkon,et al.  Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.

[50]  R. Bergman,et al.  Longitudinal Compensation for Fat-induced Insulin Resistance Includes Reduced Insulin Clearance and Enhanced ␤-cell Response Research Design and Methods , 2022 .

[51]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[52]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[53]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[54]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[55]  Sterling C. Johnson,et al.  The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study , 2005, BMC neurology.